marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q1
added 05-14-2024
Acorda Therapeutics Financial Ratios 2011-2024 | ACOR
Annual Financial Ratios Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.2 | -0.1 | -0.5 | -0.4 | 23.0 | -5.4 | -25.6 | 140.6 | 96.8 | 73.3 | 7.3 | 32.6 |
P/S |
0.1 | 0.1 | 0.1 | 0.4 | 0.5 | 1.6 | 2.1 | 1.7 | 3.2 | 4.3 | 3.6 | 3.7 | 3.4 |
EPS |
-203.6 | -65.2 | -9.8 | -12.3 | -34.4 | 0.7 | -4.9 | -0.8 | 0.3 | 0.4 | 0.4 | 3.9 | 0.8 |
EV (Enterprise Value) |
-13.2 M | -23.9 M | -35 M | 378 M | 528 M | 1.17 B | 1.59 B | 1.41 B | 1.92 B | 2.07 B | 1.32 B | 1.27 B | 1.11 B |
EBITDA per Share |
-188 | -2.5 | -4.24 | -6.94 | -12 | 13.4 | 16.7 | -0.769 | 8.51 | 7.88 | 5.58 | 4.6 | 6.1 |
EV/EBITDA |
0.8 | -4.0 | -2.7 | 8.0 | 9.8 | -185.4 | 28.6 | 33.8 | 31.3 | 36.6 | 23.9 | ||
PEG |
-0.0 | 0.0 | 0.0 | -0.01 | 0.0 | 0.2 | 0.01 | 0.07 | -3.56 | 19.83 | -0.82 | 0.02 | 0.09 |
P/B |
0.2 | 0.0 | 0.0 | 0.2 | 0.3 | 1.3 | 2.3 | 1.3 | 2.6 | 3.2 | 2.7 | 2.9 | 4.9 |
P/CF |
-1.2 | -0.7 | -0.3 | -0.8 | -0.5 | 6.6 | 14.8 | -3.7 | 49.5 | -4.2 | 49.0 | 29.5 | 16.5 |
ROE % |
160.08 | -70.41 | -68.78 | -41.85 | -87.82 | 5.50 | -42.95 | -5.21 | 1.83 | 3.27 | 3.73 | 40.15 | 14.91 |
ROA % |
-232.99 | -16.66 | -22.82 | -15.74 | -34.13 | 2.59 | -18.64 | -2.58 | 0.99 | 1.64 | 2.71 | 27.41 | 8.06 |
ROCE % |
167.74 | -37.75 | -52.30 | -17.54 | -16.96 | 8.06 | 9.95 | -2.29 | 4.38 | 4.72 | 5.95 | 5.49 | 12.00 |
Current Ratio |
- | - | - | 1.6 | 2.3 | 3.8 | 3.1 | 1.8 | 5.0 | 3.6 | 3.8 | 3.4 | 4.1 |
DSO |
48.3 | 47.5 | 52.6 | 48.2 | 41.9 | 18.1 | 50.5 | 36.7 | 23.3 | 29.3 | 33.4 | 31.4 | 28.5 |
DIO |
345.2 | 188.3 | 211.3 | 312.3 | 264.2 | 106.6 | 100.9 | 145.6 | 143.3 | 121.5 | 143.3 | 132.7 | 155.6 |
DPO |
276.8 | 124.3 | 102.9 | 140.3 | 281.1 | 181.4 | 83.6 | 101.0 | 67.0 | 91.9 | 98.5 | 153.1 | 117.3 |
Operating Cycle |
393.5 | 235.8 | 263.9 | 360.5 | 306.1 | 124.8 | 151.4 | 182.3 | 166.6 | 150.8 | 176.7 | 164.1 | 184.1 |
Cash Conversion Cycle |
116.7 | 111.6 | 161.0 | 220.2 | 25.0 | -56.7 | 67.8 | 81.3 | 99.5 | 58.9 | 78.2 | 11.0 | 66.8 |
All numbers in USD currency
Quarterly Financial Ratios Acorda Therapeutics
| 2024-Q1 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-22.06 | -13.54 | - | -0.57 | -2.78 | -1.85 | - | -2.43 | -2.29 | -3.53 | - | 0.92 | -2.19 | -0.81 | 1.38 | -5.55 | -0.58 | -1 | 0.2 | -0.29 | 0.99 | -0.18 | -3.7 | -0.55 | -0.18 | -0.41 | -0.07 | -0.28 | -0.4 | -0.01 | 0.22 | 0.09 | 0.02 | -0.07 | 0.01 | 0.29 | 0.11 | 0.02 | 0.15 | 0.19 | 0.1 | -0.03 | 3.36 | 0.24 | 0.12 | 0.2 | 0.32 | 0.48 | -0.01 | -0.02 |
EBITDA per Share |
-15.1 | -2.87 | - | 0.81 | 0.18 | -0.62 | - | 0.22 | 0.15 | -2.14 | - | 5.9 | 1.4 | 0.49 | - | -4.94 | -0.18 | -0.81 | - | 0.79 | 1.4 | 0.08 | - | 0.33 | 0.31 | -0.21 | - | 0.23 | -0.09 | -0.3 | - | 0.87 | 0.31 | 0.06 | - | 0.64 | 0.36 | 0.13 | - | 0.4 | 0.29 | -0.03 | - | 0.34 | 0.18 | 0.25 | - | 0.61 | 0.08 | 0.04 |
ROE % |
-43.68 | -111.54 | -90.61 | -107.07 | -105.25 | -64.15 | -44.68 | -41.59 | -22.04 | -17.36 | -6.95 | 14.17 | -73.70 | -75.23 | -87.82 | -107.38 | -24.86 | -8.47 | 5.35 | -29.11 | -31.69 | -40.81 | -42.95 | -10.52 | -7.63 | -8.88 | -5.32 | -3.33 | -0.69 | 2.30 | 1.87 | 0.40 | 1.93 | 2.63 | 3.27 | 4.62 | 4.10 | 4.12 | 3.73 | 36.78 | 37.57 | 37.86 | 40.15 | 11.88 | 18.59 | 17.27 | 14.91 | 9.19 | -0.14 | -0.33 |
ROA % |
-45.11 | -23.02 | -20.79 | -26.60 | -28.89 | -22.05 | -16.19 | -15.03 | -8.06 | -6.16 | -2.62 | 5.60 | -28.52 | -29.20 | -34.13 | -41.60 | -9.72 | -2.73 | 2.59 | -12.43 | -13.46 | -17.70 | -18.64 | -4.60 | -3.46 | -4.19 | -2.65 | -1.59 | -0.27 | 1.23 | 1.00 | 0.20 | 0.95 | 1.29 | 1.64 | 2.62 | 2.75 | 2.96 | 2.71 | 25.21 | 25.67 | 25.83 | 27.41 | 7.23 | 10.51 | 9.63 | 8.06 | 4.97 | -0.08 | -0.18 |
ROCE % |
-17.52 | -43.91 | -35.51 | -49.50 | -56.90 | -49.31 | -36.18 | -29.44 | -8.71 | -4.49 | 0.13 | -83.31 | -173.49 | -177.00 | -104.92 | -100.30 | -12.23 | 4.94 | 14.35 | 13.94 | 8.90 | -0.23 | -2.83 | -3.65 | -4.06 | -6.67 | -5.42 | -0.96 | 4.33 | 7.37 | 5.20 | 9.06 | 8.45 | 9.53 | 6.52 | 9.10 | 7.83 | 7.78 | 4.00 | 6.69 | 6.79 | 6.12 | 6.29 | 16.36 | 23.75 | 22.88 | 10.73 | 10.07 | 0.45 | 0.21 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
41.3 | 47.3 | - | 39.4 | 38.6 | 58.7 | - | 40.0 | 44.9 | 59.3 | - | 34.7 | 54.8 | 68.6 | 39.9 | 42.2 | 40.3 | 47.0 | 30.9 | 15.0 | 13.9 | 45.0 | 39.4 | 52.7 | 53.3 | 51.1 | - | 35.1 | 37.4 | 33.0 | - | 19.4 | 25.2 | 29.1 | - | 27.7 | 30.3 | 35.7 | - | 33.1 | 32.3 | 36.3 | - | 31.0 | 31.8 | 31.5 | - | 22.4 | 31.9 | - |
DIO |
339.5 | 369.9 | - | 126.8 | 156.3 | 255.3 | - | 157.6 | 212.6 | 214.0 | - | 215.0 | 393.0 | 639.9 | - | 288.2 | 244.9 | 281.2 | - | 105.3 | 87.2 | 147.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
157.4 | 178.7 | - | 80.7 | 86.7 | 150.0 | - | 113.1 | 108.7 | 82.6 | - | 91.1 | 166.6 | 456.0 | - | 300.0 | 255.0 | 389.5 | - | 177.3 | 146.8 | 168.6 | - | 83.3 | 84.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
380.8 | 417.1 | - | 166.2 | 194.9 | 314.0 | - | 197.6 | 257.6 | 273.2 | - | 249.7 | 447.8 | 708.5 | 39.9 | 330.4 | 285.2 | 328.3 | 30.9 | 120.2 | 101.1 | 192.1 | 39.4 | 52.7 | 53.3 | 51.1 | - | 35.1 | 37.4 | 33.0 | - | 19.4 | 25.2 | 29.1 | - | 27.7 | 30.3 | 35.7 | - | 33.1 | 32.3 | 36.3 | - | 31.0 | 31.8 | 31.5 | - | 22.4 | 31.9 | - |
Cash Conversion Cycle |
223.5 | 238.5 | - | 85.5 | 108.2 | 164.0 | - | 84.5 | 148.9 | 190.7 | - | 158.6 | 281.2 | 252.5 | 39.9 | 30.4 | 30.2 | -61.2 | 30.9 | -57.0 | -45.7 | 23.6 | 39.4 | -30.6 | -30.9 | 51.1 | - | 35.1 | 37.4 | 33.0 | - | 19.4 | 25.2 | 29.1 | - | 27.7 | 30.3 | 35.7 | - | 33.1 | 32.3 | 36.3 | - | 31.0 | 31.8 | 31.5 | - | 22.4 | 31.9 | - |
All numbers in USD currency